Alexis Brice – Director, Brain & Spine Institute (ICM), France
Prof. Alexis Brice, director of the French Brain & Spine Institute (Institut du Cerveau et de la Moelle épinière (ICM)), reveals the recipe behind the success of the center since…
Address: 26 Kallang Place #05-17 Singapore 339157,Singapore
Tel: + (65) 6299 5411
Web: http://www.icmpharma.com.sg/
ICM started in Singapore as a trading entity in 1970 under the name of Woods International Pte Ltd, which now becomes the marketing arm of veterinary products in Singapore and Malaysia. It is also their official tendering agency for pharmaceutical products to the public sector in Singapore.
There manufacturing activities started in 1975 for the range of veterinary products under Carrington brand. In the 1980s, they obtained Good Manufacturing Practice (GMP) certification from Ministry of Health (Singapore) for production of human pharmaceuticals. Thier facilities are capable of producing oral preparations, external preparations, creams and ointments.
ICM is now one of the largest local pharmaceutical manufacturers in Singapore. They have expanded into an organisation with over 60 staffs, headed by a group of professionals including pharmacists, quality control and R&D chemists, microbiologist and trained technicians
Their product range includes pharmaceuticals (both ethical and over-the-counter), cosmetics, household products and chemicals for industrial uses. They also do packing of solid dosage forms such as tablets and capsules for their clients.
Prof. Alexis Brice, director of the French Brain & Spine Institute (Institut du Cerveau et de la Moelle épinière (ICM)), reveals the recipe behind the success of the center since…
Victor Manuel Fernández Navarro, CEO at Vicma, explains how strategically important is to have a healthy business model in the distribution industry through sustainable collection period, attractive profit margins and…
Bayer’s Dr Vincent Ruland highlights his career trajectory from medical doctor to pharma country manager; the company’s priorities in Malaysia, Singapore, and Brunei; and leveraging the Asian innovation ecosystem. …
The SGC’s Dr Tim Philippi introduces the sizeable Singaporean-German trading relationship and the importance of healthcare and the life sciences within it. Dr Philippi also outlines the impact of the…
Japanese medtech player Terumo’s APAC lead Probir Das outlines the company’s 100-year commitment to innovation, its aggressive globalisation strategy over the last 15 years, the importance of the APAC region…
The ongoing COVID-19 pandemic is a double-edged sword for Singapore. While its economy has been hit by the global crisis, the island city-state is seeing an uptick in pharmaceutical manufacturing…
A roundup of some of the most significant healthcare and life science stories from across Singapore and the Asia-Pacific region, including the ongoing hunt for a COVID-19 vaccine and a…
Vishal Doshi, founder and CEO of AUM Biosciences, shares his motivation behind establishing the company and his mission to build an ecosystem within AUM for a decentralized biotech innovation model;…
Dr Charles Stacey, president and CEO of Brain Health company Cerecin, formerly Accera, discusses the rebrand, new investment, the company’s relocation to Asia, and the upcoming rollout of a global…
Rhenu Bhuller, a founding member of Frost & Sullivan’s Asia Pacific operations and expert in analysing the impact of cutting-edge tech, looks at pharma’s evolution and adoption of digital health.…
Ai Hua Ong, Company Group Chairman, Asia Pacific, The Janssen Pharmaceutical Companies of Johnson & Johnson. There is a clear correlation between an inclusive culture and innovation Creating a…
Claus Zieler discusses the Asia Pacific region’s importance to Bayer’s global operations, the company’s commitment to increasing its portfolio of innovative medicines, and the potential for innovation coming from Asian…
As a strong advocate for APAC, Roche Diagnostics’ Managing Director for Asia Pacific, Lance Little, shares his insights on the nuances of the markets in the region, the value proposition…
GEA, a global leader in pharma manufacturing solutions, has recently implemented a successful reorganization to increase their country-level presence both globally and across the Asia-Pacific region with the objective to…
See our Cookie Privacy Policy Here